| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |